Clopidogrel Medco Outcomes Study

Trial Profile

Clopidogrel Medco Outcomes Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2010

At a glance

  • Drugs Clopidogrel (Primary) ; Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Proton pump inhibitors; Rabeprazole
  • Indications Angina pectoris; Cardiovascular disorders; Coronary disorders; Death; Embolism and thrombosis; Gastro-oesophageal reflux; Gastrointestinal disorders; Myocardial infarction; Stroke; Transient ischaemic attacks
  • Focus Therapeutic Use
  • Acronyms CMOS
  • Most Recent Events

    • 01 Aug 2010 Primary endpoint results published in Pharmacotherapy
    • 01 Aug 2010 Elderly added as descriptor, and elderly and adults added as age keywords
    • 27 Jul 2010 Results reported in Pharmacotherapy, according to a Medco media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top